UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis

Alimentary pharmacology & therapeutics, 2019-07, Vol.50 (1), p.93-102

2019

Volltextzugriff (PDF)

Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial

Journal of digestive diseases, 2019-10, Vol.20 (10), p.547-556

2019

Volltextzugriff (PDF)

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

World journal of gastroenterology : WJG, 2014-04, Vol.20 (16), p.4702-4711

2014

Volltextzugriff (PDF)

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

Liver international, 2015-11, Vol.35 (11), p.2392-2400

2015

Volltextzugriff (PDF)

The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China

Hepatobiliary & pancreatic diseases international, 2021-10, Vol.20 (5), p.426-432

2021

Volltextzugriff (PDF)

Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease

World journal of gastroenterology : WJG, 2024-03, Vol.30 (10), p.1393-1404

2024

Volltextzugriff (PDF)

A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B

Digestive and liver disease, 2017-08, Vol.49 (8), p.910-917

2017

Volltextzugriff (PDF)

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism

Journal of Diabetes Research, 2017-01, Vol.2017, p.4740124-12

2017

Volltextzugriff (PDF)

Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World journal of hepatology, 2024-01, Vol.16 (1), p.41-53

2024

Volltextzugriff (PDF)

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B

Digestive diseases and sciences, 2015-01, Vol.60 (1), p.243-251

2015

Volltextzugriff (PDF)

Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease

International journal of molecular medicine, 2018-07, Vol.42 (1), p.443-452

2018

Volltextzugriff (PDF)

APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases

Digestive diseases and sciences, 2016-08, Vol.61 (8), p.2284-2293

2016

Volltextzugriff (PDF)

Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients

World journal of gastroenterology : WJG, 2020-08, Vol.26 (30), p.4501-4522

2020

Volltextzugriff (PDF)

Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B

World journal of gastroenterology : WJG, 2015-07, Vol.21 (28), p.8605-8614

2015

Volltextzugriff (PDF)

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

Journal of clinical and translational hepatology, 2023-04, Vol.11 (2), p.304-313

2023

Volltextzugriff (PDF)

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Journal of clinical and translational hepatology, 2021-10, Vol.9 (5), p.607-614

2021

Volltextzugriff (PDF)

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

Journal of digestive diseases, 2019-04, Vol.20 (4), p.163-173

2019

Volltextzugriff (PDF)

Guidelines of prevention and treatment for alcoholic liver disease (2018, China)

Journal of digestive diseases, 2019-04, Vol.20 (4), p.174-180

2019

Volltextzugriff (PDF)

Relationship between HBV-DNA in peripheral blood mononuclear cells and syndrome types of TCM in chronic hepatitis B patients

Zhongguo Zhong xi yi jie he za zhi, 2007-04, Vol.27 (4), p.296

2007

Volltextzugriff (PDF)

Hepatic sarcoidosis with severe jaundice leading to cirrhosis: a case report

Zhonghua gan zang bing za zhi, 2007-08, Vol.15 (8), p.629

2007

Volltextzugriff (PDF)

Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis

Zhonghua gan zang bing za zhi, 2009-11, Vol.17 (11), p.817

2009

Volltextzugriff (PDF)

The correlation of HBeAg expression and HBV-DNA in serum or peripheral blood mononuclear cells in patients with chronic hepatitis B

Zhonghua shi yan he lin chuang bing du xue za ji, 2007-09, Vol.21 (3), p.261

2007

Volltextzugriff (PDF)

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan.sup.®: Validation in Chronic Hepatitis B

Digestive diseases and sciences, 2015-01, Vol.60 (1), p.243

2015

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(64)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(34)
Humans
(24)
Female
(18)
Gastroenterology & Hepatology
(18)
Male
(16)
Middle Aged
(15)
Adult
(14)
Animals
(8)
Body Mass Index
(8)
Fatty Liver
(7)
Hepatitis B
(7)
Liver - Pathology
(7)
Aged
(6)
Biopsy
(6)
Diagnosis
(6)
China
(5)
Genetic Aspects
(5)
Hepatitis B, Chronic - Pathology
(5)
Non-Alcoholic Fatty Liver Disease - Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis

Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis

Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China

Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease

A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism

Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B

Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease

APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases

Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients

Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

Guidelines of prevention and treatment for alcoholic liver disease (2018, China)

Relationship between HBV-DNA in peripheral blood mononuclear cells and syndrome types of TCM in chronic hepatitis B patients

Hepatic sarcoidosis with severe jaundice leading to cirrhosis: a case report

Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis

The correlation of HBeAg expression and HBV-DNA in serum or peripheral blood mononuclear cells in patients with chronic hepatitis B

Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan.sup.®: Validation in Chronic Hepatitis B

Suchergebnisse filtern